Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 5
1996 12
1997 9
1998 4
1999 9
2000 5
2001 14
2002 9
2003 5
2004 7
2005 4
2006 7
2007 10
2008 11
2009 10
2010 10
2011 12
2012 14
2013 8
2014 6
2015 15
2016 12
2017 10
2018 10
2019 9
2020 6
2021 9
2022 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

214 results

Results by year

Filters applied: . Clear all
Page 1
Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation.
Olson A, Lin R, Marin D, Rafei H, Bdaiwi MH, Thall PF, Basar R, Abudayyeh A, Banerjee P, Aung FM, Kaur I, Abueg G, Rao S, Chemaly R, Mulanovich V, Al-Atrash G, Alousi AM, Andersson BS, Anderlini P, Bashir Q, Castro KM, Daher M, Galvan IM, Hosing C, Im JS, Jones RB, Kebriaei P, Khouri I, Mehta R, Molldrem J, Nieto Y, Oran B, Popat U, Qazilbash M, Rondon G, Saini N, Spencer B, Srour S, Washington D, Barnett M, Champlin RE, Shpall EJ, Rezvani K. Olson A, et al. Among authors: anderlini p. J Clin Oncol. 2021 Aug 20;39(24):2710-2719. doi: 10.1200/JCO.20.02608. Epub 2021 Apr 30. J Clin Oncol. 2021. PMID: 33929874 Free PMC article. Clinical Trial.
Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies.
Singh H, Srour SA, Milton DR, McCarty J, Dai C, Gaballa MR, Ammari M, Olivares S, Huls H, De Groot E, Marin D, Petropoulos D, Olson AL, Anderlini P, Im JS, Khouri I, Hosing CM, Rezvani K, Champlin RE, Shpall EJ, Cooper LJN, Kebriaei P. Singh H, et al. Among authors: anderlini p. Front Immunol. 2022 Nov 10;13:1032397. doi: 10.3389/fimmu.2022.1032397. eCollection 2022. Front Immunol. 2022. PMID: 36439104 Free PMC article. Clinical Trial.
Allogeneic transplantation for Hodgkin lymphoma.
Peggs KS, Anderlini P, Sureda A. Peggs KS, et al. Among authors: anderlini p. Br J Haematol. 2008 Nov;143(4):468-80. doi: 10.1111/j.1365-2141.2008.07349.x. Epub 2008 Aug 15. Br J Haematol. 2008. PMID: 18710379 Free article. Review.
Can we cure refractory Hodgkin's lymphoma with transplantation?
Ciurea SO, Kongtim P, Srour S, Saini N, Im J, Ramdial J, Khouri I, Anderlini P, Popat U, Hosing C, Champlin RE, Lee HJ, Fayad LE, Hagemeister FB, Bica AM, Lipan L, Craciun O, Jercan CG, Tanase A, Colita A. Ciurea SO, et al. Among authors: anderlini p. Bone Marrow Transplant. 2021 Jan;56(1):278-281. doi: 10.1038/s41409-020-0989-z. Epub 2020 Jul 7. Bone Marrow Transplant. 2021. PMID: 32636464 No abstract available.
Allogeneic peripheral blood stem cell collection as of 2008.
Rhodes B, Anderlini P. Rhodes B, et al. Among authors: anderlini p. Transfus Apher Sci. 2008 Jun;38(3):219-27. doi: 10.1016/j.transci.2008.04.011. Epub 2008 May 22. Transfus Apher Sci. 2008. PMID: 18501676 Free PMC article. Review.
214 results